Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Memory decline among menopausal women could be next research frontier for hypnotic relaxation therapy

  • Immersed in violence: How 3-D gaming affects video game players

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • No relationship between moderate adolescent cannabis use, exam results or IQ, large study shows

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

  • Key factor in transition from moderate to problem drinking

  • A rich vocabulary can protect against cognitive impairment

  •